Pages

.

Showing posts with label Alert. Show all posts
Showing posts with label Alert. Show all posts

Media Alert; NXT-ID Chief Technology Officer Comments on Why You Need a Smart Wallet

SHELTON, Conn., Oct. 27, 2014 /PRNewswire/ -- NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ("NXT-ID" or the "Company"), a biometric authentication company focused on the growing mobile commerce market issues a recent blog entry from Mr. David Tunnell, Chief Technology Officer. Mr Tunnell examines the case for a smart wallet like Wocket™.

With the variety of new payment solutions being released, consumers may ask which method is best? Each new payment method has its own attributes that promise to make payments more convenient and secure. The good news is that none of these new payment methods are mutually exclusive to one another. Each has its own merit depending on where it can be used. For instance, digital wallets such as Google Wallet, Apple Pay or SoftCard (formally ISIS) may be preferable for locations that accept NFC (Near Field Communications), while another solution might be a better choice for locations that require a new barcode payment system such as being developed by major retailers like Wal-Mart, Target and Best Buy. Since none of the new payment methods can be used universally at all locations, the question remains – do you still need a wallet?

Most digital wallets have one thing in common: They all are dependent upon a cell phone. Each new payment method added to a cell phone can be advantageous, depending on when and where you wish to make a payment, but there are always instances where a cell-phone based payment method may not be practical.  A cell phone based payment solution may not be practical when:

Getting money from an ATM. Making a purchase at one of the millions of retail outlets that have not yet replaced their existing point of sale (POS) terminals with new upgraded ones. Making payments in areas with poor connectivity to the Internet. There is a risk that your cell phone battery might run out. Bluetooth does not pair, which may occur with certain methods that require Bluetooth connection with the phone. Then, there is the issue of cash. There are still instances you may need cash or other private information that you want to secure but can't afford to leave at home. These are just some examples of when you may wish you had your wallet with you. 

Smart wallets add electronics to wallets and purses so that you keep your private information secure, only accessible by you. Smart wallets also securely store all of your personal information, not just payment accounts. Furthermore, smart wallets are agnostic to the payment method, capable of supporting new payment methods as they emerge.

So, no matter whether you choose one or more new payment methods associated with your cell phone, there will always be a reason you wished you had a smart wallet. 

We encourage you to take a look at the features of the Wocket™ Smart Wallet and how it might benefit not only your shopping experience, but also all aspects of your wallet by giving you peace of mind with added security to all your personal information.

About NXT- ID Inc. - Mobile Security for a Mobile World: (NXTD) (NXTDW):

NXT-ID, Inc.'s innovative MobileBio® solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio® suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.wocketwallet.com

NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification that has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com, http://3d-id.net.

Forward-Looking Statements for NXT-ID:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Contact:

Corporate info: info@nxt-id.com
Investor Inquiries: Kirin Smith
ProActive Capital Group
Direct: +1-646-863-6519
ksmith@proactivecapital.com
Media: 800-665-0411
dvanzant@investorideas.com

SOURCE NXT-ID, Inc.

RELATED LINKS
http://www.wocketwallet.com
http://www.nxt-id.com

reade more... Résuméabuiyad

Media Alert: Olivia Culpo, Former Miss Universe 2012, to Attend NXT-ID's Corporate Event for Wocket™ Smart Wallet at Plaza Hotel May 28th

SHELTON, Connecticut, May 28, 2014 /PRNewswire/ -- NXT-ID, Inc., (OTCQB: NXTD) (OTCBB: NXTD) a biometric authentication company focused on the growing m-commerce market, announces Olivia Culpo, former Miss Universe , Miss USA and Miss Rhode Island, will be a celebrity guest attending the corporate launch event and press conference for its next generation, biometrically secure smart wallet, Wocket™.

The event will take place today on May 28th at the Plaza Hotel from 3:00- 5:00 p.m.

The event will give consumers and media a first-hand look at the Wocket™ Smart Wallet and  the Wocket™ Card.  Following the event, consumers will be able to pre-order Wocket™ online by visiting: http://www.wocketwallet.com/.

Wocket™ is a next generation smart wallet designed to protect your identity and replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.

The Wocket product FAQ is available to consumers and media at http://www.wocketwallet.com/

To attend please send requests to info@nxt-id.com or call 800-665-0411.

About Olivia Culpo:

Olivia Culpo was crowned Miss Universe 2012. She was the first American representative in 15 years to win the title. Earlier that year, representing the State of Rhode Island, Culpo also won the title of Miss USA.

About NXT-ID Inc. - Mobile Security for a Mobile World

NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/ and http://www.wocketwallet.com/

NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/

Forward-Looking Statements for NXT-ID

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Contact:
Corporate info: info@nxt-id.com

Investor Inquiries:
Kirin Smith, ProActive Capital Group
Direct: +1-646-863-6519
ksmith@proactivecrg.com

Media: 800-665-0411

SOURCE NXT-ID, Inc.

RELATED LINKS
http://www.nxt-id.com

reade more... Résuméabuiyad

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT

NEW YORK, June 27, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: PVCT) and certain of its officers.  The class action, filed in United States District Court, Middle District of Tennessee, Nashville Division, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Provectus securities between December 17, 2013 and May 22, 2014, both dates inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

If you are a shareholder who purchased Provectus securities during the Class Period, you have until July 28, 2014 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

Provectus is a development-stage biopharmaceutical company that focuses on developing pharmaceuticals for oncology and dermatology indications. The most important drug in the Company's pipeline is an oncology drug, PV-10, which is intended for the treatment of several life threatening cancers, including metastatic melanoma, liver cancer, and breast cancer. 

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company utilized the services of paid stock promoters to inflate its share price; (ii) contrary to the Company's representations, preparations were not underway for a Phase 3 study for PV-10; and (iii) the Company improperly referred to PV-10 as obtaining a Breakthrough Therapy Designation ("BTD"), and otherwise implied that obtaining that status was inevitable.

On January 23, 2014, an article was published on TheStreet.com, accusing Provectus of artificially inflating the price of its stock by making false representations related to the commencement of Phase III clinical trials. 

On this news, the Company's shares declined $3.35, or over 64%, to close at $21.87 on January 23, 2014.

Prior to May 20, 2014, the Company's website improperly described its PV-10 drug as a "breakthrough" drug for skin cancer, prior to the FDA's designation of the drug as such.  On May 20, 2014, the Company updated its website and changed the description of PV-10 to "An Investigational Drug for Cancer" and included language clearly indicating that the drug was still awaiting BTD designation by the FDA.

On this news, Provectus securities declined $0.31 per share, or over 10%, to close at $2.70 per share on May 20, 2014.

On May 21, 2014, an article was published on SeekingAlpha.com alleging that the Company was tied to stock promoters that improperly marketed the Company's stock to unsophisticated retail investors, thus artificially inflating the price of the Company's shares.  The article noted that trading in many of the other companies associated with these stock promoters was recently halted by the SEC.  That same day, Provectus issued a press release refuting the allegations of the SeekingAlpha.com article.  Provectus specifically noted that PV-10, its investigational metastatic melanoma therapy, had not failed the breakthrough therapy designation, but was awaiting a decision from the FDA as to the status of its request. Additionally, Provectus further denied any affiliation with stock promoters.

On this news, the Company's shares declined $0.46, or over 17%, to close at $2.24 on May 21, 2014.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

SOURCE Pomerantz LLP

RELATED LINKS
http://www.pomerantzlaw.com

reade more... Résuméabuiyad

Event Alert: Kinaxis Executive to Present "Continuous S&OP - Breaking the Mold" at LogiPharma Europe 2014

www.kinaxis.com. (PRNewsFoto/Kinaxis)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";OTTAWA, Ontario, March 24, 2014 /PRNewswire/ -- Kinaxis®, provider of RapidResponse®, a cloud-based SCM and S&OP service, is proud to be a sponsor of LogiPharma 2014, which will be held April 8 – 9, 2014 at the Congress Center Basel in Basel, Switzerland.

Event Details
Join Trevor Miles, vice president of thought leadership and industry principle, life sciences at Kinaxis on Wednesday, April 9th, 2014 at 3:55p.m., as he presents "Continuous S&OP – Breaking the Mold". In this session, he will discuss how business and technology has changed tremendously in the thirty years since S&OP was first defined, enabling much more proficient and integrated S&OP processes. Trevor will describe how companies are breaking the traditional S&OP mold from both a process and technology perspective.  In addition, Mr. Miles will moderate a roundtable discussion: "Leveraging the Cloud to Achieve True Innovation in Supply Chain Management" on Tuesday, April 8th at 4:15p.m.

During the conference follow hashtag #LogiPharma  and stop by the Kinaxis booth #21 to meet with the team and learn more about how Kinaxis has helped life science companies adopt process improvements and technology targeted at removing business "silos," improving collaboration, and achieving significant operations performance breakthroughs. Find out more about RapidResponse for life sciences at: http://kinax.is/pharm.

For more Kinaxis news, follow us on LinkedIn, Twitter or Facebook.

About Kinaxis
Kinaxis delivers cloud-based S&OP and supply chain solutions for discrete manufacturers and brand owners with complex supply chain networks and volatile business environments. Leaders across multiple industry verticals, including A&D, Automotive, High Tech, Industrial and Life Sciences rely on RapidResponse for concurrent planning, continuous performance monitoring, and coordinated responses to plan variances across multiple areas of the business. RapidResponse's configurable service solutions encompass a full spectrum of supply chain related business processes, including such functions as: S&OP, supply planning, capacity planning, demand planning, inventory management, MPS and order fulfillment. As a result, Kinaxis customers have replaced disparate planning and performance management tools and are realizing significant operations performance breakthroughs in planning cycles, supply chain response times and decision accuracy. From a single product, customers are able to easily model varying supply chain conditions to make both long-term and real-time demand and supply balancing decisions quickly, collaboratively, and in line with the shared business objectives of multiple stakeholders.

Contact:
Melissa Clow
mclow@kinaxis.com 

Logo - http://photos.prnewswire.com/prnh/20120208/CG49456LOGO-b

SOURCE Kinaxis

RELATED LINKS
www.kinaxis.com

reade more... Résuméabuiyad